For the Quarter Ending March 2026
Ampicillin Prices in North America
- In United States, the Ampicillin Price Index rose quarter-over-quarter in Q1 2026, driven by elevated production costs.
- The Ampicillin Production Cost Trend increased in March 2026 as the Producer Price Index rose 4.0% year-over-year.
- The Ampicillin Demand Outlook strengthened in Q1 2026, supported by a 4.0% year-over-year increase in retail sales.
- The Ampicillin Price Forecast reflected upward momentum in March 2026, influenced by a 3.3% year-over-year CPI increase.
- Industrial production grew 0.7% year-over-year in March 2026, while the Manufacturing Index expanded, supporting steady pharmaceutical operations.
- A stable 4.3% unemployment rate and a 91.8 consumer confidence index in March 2026 sustained healthcare utilization.
- Hospital procurement of injectable antibiotics remained robust in January 2026 amid elevated admissions for bacterial infections.
- Domestic pharmaceutical inventories experienced a retrenchment in Q1 2026, while US import volumes of ingredients decelerated.
- US domestic supply tightened following the discontinuation of specific ampicillin sodium injection product lines in January 2026.
Why did the price of Ampicillin change in March 2026 in North America?
- Environmental compliance and effluent treatment upgrades elevated baseline manufacturing expenses for key intermediates in Q1 2026.
- Stockpiles of finished generic formulations tightened amid supply chain realignments and biosecurity policies in February 2026.
- Pharmaceutical demand for broad-spectrum antibiotics strengthened during the winter respiratory infection season in Q1 2026.
Ampicillin Prices in APAC
- In China, the Ampicillin Price Index rose quarter-over-quarter in Q1 2026, driven by escalating production costs and firm demand.
- The Producer Price Index increased 0.5% in March 2026, elevating the Ampicillin Production Cost Trend through cost-push pressures.
- A 1.0% Consumer Price Index rise in March 2026 supported a consistent Ampicillin Demand Outlook in domestic pharmaceutical markets.
- Industrial production grew 5.7% in March 2026, ensuring steady synthesis and ample supply of essential Ampicillin pharmaceutical ingredients.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, dampening veterinary Ampicillin consumption across agricultural sectors.
- Consumer confidence hit 91.6 in February 2026, while the manufacturing index expanded during March 2026, indicating robust factory activity.
- Past data shaped the Ampicillin Price Forecast as 6-APA feedstock costs strengthened in February 2026, driving values upward.
- Indian import restrictions disrupted Ampicillin intermediate export flows in January 2026, weakening overall international trade volumes for the quarter.
Why did the price of Ampicillin change in March 2026 in APAC?
- Strict environmental compliance monitoring exerted upward cost pressure on Ampicillin fermentation operations throughout Q1 2026.
- Broader energy-intensive manufacturing costs for active pharmaceutical ingredients escalated significantly throughout Q1 2026, impacting production expenses.
- Strong domestic hospital procurement for Ampicillin-based antibacterial medications held firm throughout Q1 2026, supporting upward price momentum.
Ampicillin Prices in Europe
- In Germany, the Ampicillin Price Index rose quarter-over-quarter in Q1 2026, driven by escalating energy costs.
- The Ampicillin Production Cost Trend increased in March 2026 as energy-intensive fermentation processes faced surging expenses.
- The Ampicillin Demand Outlook strengthened in January 2026 as domestic manufacturing orders surged from large contracts.
- The Ampicillin Price Forecast faced upward revisions in March 2026 amid 2.7% consumer inflation.
- The Ampicillin Price Index faced downward pressure as the producer price index declined 0.2% in March 2026.
- The Manufacturing Index expanded in March 2026, reflecting robust activity in pharmaceutical formulation and chemicals.
- Industrial production remained flat at 0.0% in February 2026, reflecting stable baseline chemical manufacturing activity.
- Retail sales grew 0.7% in February 2026, supporting consistent pharmaceutical off-take and Ampicillin consumption.
- Low unemployment at 4.2% in February 2026 sustained healthcare access, supporting human and veterinary antibiotic use.
- Consumer confidence fell to -24.7 in March 2026, negatively impacting the veterinary segment of Ampicillin demand.
Why did the price of Ampicillin change in March 2026 in Europe?
- Energy prices surged significantly in March 2026, escalating operational costs for energy-intensive Ampicillin fermentation processes.
- The Strait of Hormuz closure in March 2026 disrupted natural gas supplies, increasing production costs.
- Strong domestic manufacturing orders in January 2026 increased demand for intermediate pharmaceutical goods and APIs.
For the Quarter Ending December 2025
Ampicillin Prices in North America
- In the United States, the Ampicillin Price Index rose in Q4 2025, driven by increasing production costs and robust demand.
- Ampicillin production costs increased due to a 3.0% year-over-year PPI rise in November 2025, impacting input materials.
- Consumer Price Index (CPI) increased 2.7% year-over-year in December 2025, raising overall manufacturing expenses.
- Ampicillin demand outlook remained strong, supported by a 2.0% year-over-year industrial production increase in December 2025.
- Retail sales grew 3.3% year-over-year in November 2025, indirectly boosting healthcare spending and Ampicillin demand.
- The unemployment rate of 4.4% in December 2025 supported consumer healthcare access, strengthening Ampicillin demand.
- Natural gas spot prices gradually rose in the final months of 2025, increasing energy costs for Ampicillin production.
- US biopharmaceutical companies made substantial manufacturing investments during Q4 2025, strengthening the Ampicillin supply chain.
Why did the price of Ampicillin change in December 2025 in North America?
- Rising production costs, evidenced by a 3.0% PPI increase in November 2025, pushed Ampicillin prices upward.
- Strong consumer spending, with retail sales up 3.3% in November 2025, supported robust Ampicillin demand.
- Increased energy expenses, as natural gas spot prices rose in Q4 2025, contributed to higher Ampicillin costs.
Ampicillin Prices in APAC
- In China, the Ampicillin Price Index fell in Q4 2025, influenced by a 1.9% Producer Price Index decline in December 2025.
- Ampicillin production costs decreased in Q4 2025, driven by expanded 6-APA capacity and refined industrial power pricing.
- Demand for Ampicillin remained robust in 2025, supported by China's growing pharmaceutical market and rising healthcare needs.
- The Ampicillin demand outlook was bullish in December 2025, as industrial production grew by 5.2% year-on-year.
- Manufacturing activity expanded in December 2025, with the Manufacturing Index indicating growth, supporting supply.
- Inventory levels for chemical derivatives were reasonable in October 2025, reflecting restrained purchasing.
- Pharmaceutical product exports from China decreased between October and November 2025, while imports also declined.
- The Consumer Price Index rose mildly by 0.8% year-on-year in December 2025, indicating stable operational costs.
Why did the price of Ampicillin change in December 2025 in APAC?
- Production costs declined due to a 1.9% year-on-year fall in the Producer Price Index in December 2025.
- Robust industrial production, up 5.2% year-on-year in December 2025, bolstered demand.
- Cautious consumer spending, with retail sales growing 0.9% year-on-year in December 2025, impacted demand.
Ampicillin Prices in Europe
- In Germany, the Ampicillin Price Index fell quarter-over-quarter in Q4 2025, driven by disappointing demand and contracting manufacturing.
- Ampicillin production costs faced upward pressure from rising energy prices and elevated natural gas futures in Q4 2025.
- Demand for Ampicillin weakened throughout Q4 2025, as the German chemical industry's business climate deteriorated in October 2025.
- Producer Price Index declined by 2.5% year-over-year in December 2025, offering some relief in industrial input costs.
- Increased competitive pressure from abroad compelled German chemical companies to lower prices in October 2025.
- Consumer confidence remained pessimistic at -17.5 and unemployment stood at 6.2% in December 2025.
- Industrial production rose by 0.8% in October 2025, while retail sales increased by 1.1% in November 2025.
- Consumer Price Index rose by 1.8% year-over-year in December 2025, indicating general inflation impacting operational costs.
Why did the price of Ampicillin change in December 2025 in Europe?
- Disappointing demand in the European chemical sector throughout Q4 2025 exerted downward pressure on prices.
- Increased competitive pressure from a significant wave of imports in Q4 2025 led to price reductions.
- A contracting Manufacturing Index in December 2025 signaled a weaker economic environment, impacting pricing.
For the Quarter Ending September 2025
AmpicillinB Prices in North America
- In the United States, the Ampicillin Price Index rose in Q3 2025, driven by increased production costs and robust demand.
- Ampicillin production costs increased due to a 2.6% year-over-year PPI rise in August 2025 and higher naphtha costs.
- Demand for Ampicillin was supported by strengthened US pharmaceutical market sentiment and a 5.42% year-over-year retail sales increase.
- Overall chemical manufacturing costs rose in Q3 2025, with CPI rising 3.0% year-over-year in September 2025.
- Industry inventories for chemicals tightened in Q3 2025 due to accelerating destocking, impacting supply.
- US chemical production contracted in Q3 2025, despite 0.1% industrial production growth in September 2025.
- The Ampicillin Price Forecast indicates continued upward pressure due to persistent cost inflation and sustained healthcare demand.
- A low unemployment rate of 4.3% in September 2025 supported healthcare access, bolstering Ampicillin demand.
- Why did the price of Ampicillin change in September 2025 in North America?
- Production costs increased due to rising naphtha feedstock and Henry Hub natural gas prices in September 2025.
- Stronger US pharmaceutical market sentiment and health system rebound boosted Ampicillin demand in Q3 2025.
- Tightening industry inventories and contracting US chemical production reduced supply in Q3 2025.
AmpicillinB Prices in Europe
- In Germany, Ampicillin Price Index rose in Q3 2025, driven by high energy and raw material costs.
- Ampicillin production costs increased due to elevated natural gas and electricity prices across Europe in Q3 2025.
- German chemical industry faced rising input costs, with CPI increasing 2.4% in September 2025, impacting Ampicillin manufacturing.
- Ampicillin demand outlook remains moderately expanding, supported by an aging population and rising chronic diseases.
- The Manufacturing Index was contracting in September 2025, indicating a slowdown in industrial activity affecting chemical demand.
- Industrial production declined 1.0% year-over-year in September 2025, impacting Ampicillin supply chain stability.
- Despite a -1.7% PPI decrease in September 2025, energy cost pressures remained significant for Ampicillin production.
- Ampicillin price forecast reflects sustained cost drivers and moderate pharmaceutical market growth.
Why did the price of Ampicillin change in September 2025 in Europe?
- Elevated natural gas and electricity prices in Europe increased Ampicillin production costs in Q3 2025.
- German chemical industry faced high raw material costs, with CPI increasing 2.4% in September 2025.
- Contracting Manufacturing Index in September 2025 indicated softening industrial demand, influencing Ampicillin.
AmpicillinB Prices in APAC
- In China, the Ampicillin Price Index fell in Q3 2025, influenced by broader chemical overcapacity and deflationary pressures.
- Ampicillin demand strengthened in Q3 2025, driven by increased reliance on penicillin-based antibiotics and rising healthcare needs.
- Ampicillin production costs faced upward pressure in Q3 2025 due to increased US tariffs on pharmaceutical imports.
- Utility costs for Ampicillin manufacturing rose in Q3 2025, influenced by elevated Brent crude oil prices.
- China's Manufacturing Index was contracting in September 2025, signaling a slowdown in overall industrial activity.
- Industrial production increased by 6.5% year-on-year in September 2025, supporting economic growth.
- The Consumer Price Index (CPI) declined by 0.3% year-on-year in September 2025, indicating deflationary pressures.
- The Producer Price Index (PPI) fell by 2.3% year-on-year in September 2025, suggesting lower factory-gate prices.
Why did the price of Ampicillin change in September 2025 in APAC?
- Increased US tariffs on pharmaceutical imports elevated API input costs in Q3 2025.
- China's broader chemical sector experienced amplified overcapacity during Q3 2025.
- The Consumer Price Index (CPI) declined by 0.3% year-on-year in September 2025.
For the Quarter Ending December 2022
North America
The fourth quarter of 2022 saw changing market trends for Ampicillin Trihydrate API in the North American region. Prices were expected to increase through the second month of the quarter starting with Q4 2022 because of the high cost of manufacturing, numerous logistical issues, and growing inflation.
Rising transportation costs and port congestion at the key ports also helped to keep the market position strong. Due to easing inflation and lowering end-user sector demand on the back of nearing festival season and impeding holidays, prices started to drop later in December 2022. The settlement price for Ampicillin Trihydrate API decreased to USD 45545/MT CFR Los Angeles in the month of December.
APAC
The Asia Pacific region's market for Ampicillin Trihydrate API experienced a volatile trajectory in the fourth quarter of 2022. Starting in Q4 2022, prices were observed to rise through the second month of the quarter due to rising end-user demand and a number of logistical challenges. Additionally, the market scenario was impacted by the tight zero covid rules and frequent lockdowns in the Chinese regions. The market remained competitive due to growing production costs brought on by rising energy costs as well as increased domestic production to fill orders from both local and foreign markets. However, as domestic retailers had sufficient stock on hand later in December, the cost of Ampicillin Trihydrate API decreased. Also, the ease in imports and reduced orders from both domestic and international markets kept weak. During the month of December, the settlement price of Ampicillin Trihydrate API came down to USD 39355/MT FOB Shanghai.
Europe
Ampicillin Trihydrate API pricing in the European region showed a see-saw tendency in the fourth quarter of 2022. The demand for Ampicillin Trihydrate API from the downstream pharmaceutical industry was seen to be steady. The supply chain was impacted by the continuous port congestion and supply disruption in the European region, which resulted in a rise in pricing in the first two months of Q4 2022. A further factor in the elevated trajectory of Ampicillin trihydrate API was the high freight costs. Nevertheless, December sees a price decline as a result of rising stocks and declining end-user sector demand. The settlement price for Ampicillin Trihydrate API dropped to USD 48215/MT CFR Hamburg in December.
